LON:SNG - Synairgen Share Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Synairgen plc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add GBX 16.75 -1.15 (-6.42 %) (As of 02/26/2020 09:32 AM ET) Add Compare Today's Range 16.75Now: GBX 16.75▼ 17.0150-Day Range 6.05MA: GBX 10.60▼ 17.9052-Week Range 5.50Now: GBX 16.75▼ 18.10Volume94,180 shsAverage Volume78,152 shsMarket Capitalization£18.33 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartInsider TradesHeadlines Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Synairgen plc discovers and develops drugs for respiratory diseases. It develops inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment or prevention of asthma exacerbations caused by the common cold; IFN-ß that is in Phase-I clinical trial for the treatment or prevention of chronic obstructive pulmonary disease exacerbations caused by the common cold; and LOXL2 inhibitor, which is in Phase I clinical trial for the treatment of idiopathic pulmonary fibrosis (IPF). Read More… Industry, Sector and Symbol Stock Exchange LON Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolLON:SNG Previous Symbol CUSIPN/A CIKN/A Webhttp://www.synairgen.com/ Phone+44-23-80512800Debt Debt-to-Equity RatioN/A Current Ratio5.00 Quick Ratio4.95Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales£79,000.00 Price / Sales232.03 Cash FlowGBX 3.09 per share Price / Cash Flow5.42 Book ValueGBX 3.90 per share Price / Book4.29Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees12 Outstanding Shares109,433,000Market Cap£18.33 million Next Earnings DateN/A OptionableNot Optionable Receive SNG News and Ratings via Email Sign-up to receive the latest news and ratings for SNG and its competitors with MarketBeat's FREE daily newsletter. LSE:SNG Rates by TradingView Synairgen (LON:SNG) Frequently Asked Questions What is Synairgen's stock symbol? Synairgen trades on the London Stock Exchange (LON) under the ticker symbol "SNG." Has Synairgen been receiving favorable news coverage? Press coverage about SNG stock has been trending somewhat negative recently, according to InfoTrie Sentiment Analysis. The research group rates the sentiment of news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Synairgen earned a news impact score of -1.0 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 5.0 out of 10, meaning that recent news coverage is somewhat likely to have an impact on the stock's share price in the immediate future. View News Stories for Synairgen. Who are some of Synairgen's key competitors? Some companies that are related to Synairgen include Biotron (BIT), Orgenesis (ORGS), Pediapharm (PDP), Orthocell (OCC), Acasti Pharma (ACST), Verona Pharma (VRP), Medlab Clinical (MDC), IntelGenx Technologies (IGX), Promis Neurosciences (PMN), Asterias Biotherapeutics (AST), Zelda Therapeutics (ZLD), Protalix Biotherapeutics (PLX), ReNeuron Group (RENE), OptiBiotix Health (OPTI) and Immunoprecise Antibodies (IPA). What other stocks do shareholders of Synairgen own? Based on aggregate information from My MarketBeat watchlists, some companies that other Synairgen investors own include Yamana Gold (YRI), Polo Resources (POL), Eldorado Gold (ELD), Silvercorp Metals (SVM), Nippon Dragon Resources (NIP), Ariana Resources (AAU), Big Yellow Group (BYG), Costain Group (COST), Dekeloil Public (DKL) and Fevertree Drinks (FEVR). Who are Synairgen's key executives? Synairgen's management team includes the folowing people: Mr. Richard Marsden, CEO, MD & Exec. Director (Age 51)Mr. John Ward, Fin. Director, Company Sec. & Exec. Director (Age 57)Dr. Phillip David Monk, Chairman of Scientific Advisory Board, Chief Scientific Officer & Exec. Director (Age 50)Prof. Donna Davies, Co-Founder & Member of Scientific Advisory BoardProf. Ratko Djukanovic, Co-Founder & Member of Scientific Advisory Board How do I buy shares of Synairgen? Shares of SNG and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is Synairgen's stock price today? One share of SNG stock can currently be purchased for approximately GBX 16.75. How big of a company is Synairgen? Synairgen has a market capitalization of £18.33 million and generates £79,000.00 in revenue each year. Synairgen employs 12 workers across the globe.View Additional Information About Synairgen. What is Synairgen's official website? The official website for Synairgen is http://www.synairgen.com/. How can I contact Synairgen? Synairgen's mailing address is Southampton General Hosp, Tremona Road, SOUTHAMPTON, SO16 6YD, United Kingdom. The company can be reached via phone at +44-23-80512800. MarketBeat Community Rating for Synairgen (LON SNG)Community Ranking: 1.9 out of 5 ()Outperform Votes: 141 (Vote Outperform)Underperform Votes: 225 (Vote Underperform)Total Votes: 366MarketBeat's community ratings are surveys of what our community members think about Synairgen and other stocks. Vote "Outperform" if you believe SNG will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SNG will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/26/2020 by MarketBeat.com StaffFeatured Article: Percentage Decliners
